These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 23681893

  • 1. HPAEC-PAD method for the analysis of alkaline hydrolyzates of Haemophilus influenzae type b capsular polysaccharide.
    de Haan A, van der Put RM, Beurret M.
    Biomed Chromatogr; 2013 Sep; 27(9):1137-42. PubMed ID: 23681893
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Collaborative study on saccharide quantification of the Haemophilus influenzae type b component in liquid vaccine presentations.
    Rosskopf U, Daas A, Terao E, von Hunolstein C.
    Pharmeur Bio Sci Notes; 2017 Sep; 2017():44-68. PubMed ID: 29017702
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Quantitation of low level unconjugated polysaccharide in tetanus toxoid-conjugate vaccine by HPAEC/PAD following rapid separation by deoxycholate/HCl.
    Lei QP, Lamb DH, Heller R, Pietrobon P.
    J Pharm Biomed Anal; 2000 Jan; 21(6):1087-91. PubMed ID: 10708393
    [Abstract] [Full Text] [Related]

  • 9. Haemophilus influenzae type b conjugate vaccine stability: catalytic depolymerization of PRP in the presence of aluminum hydroxide.
    Sturgess AW, Rush K, Charbonneau RJ, Lee JI, West DJ, Sitrin RD, Hennessy JP.
    Vaccine; 1999 Mar 05; 17(9-10):1169-78. PubMed ID: 10195629
    [Abstract] [Full Text] [Related]

  • 10. Improvement in the purification process of the capsular polysaccharide from Haemophilus influenzae type b by using tangential ultrafiltration and diafiltration.
    Albani SM, da Silva MR, Takagi M, Cabrera-Crespo J.
    Appl Biochem Biotechnol; 2012 Aug 05; 167(7):2068-75. PubMed ID: 22665219
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Validation of an ELISA assay for the quantification of antibodies against Haemophilus influenzae type b capsular polysaccharide].
    Toraño Peraza G, Hernández Vadell I, Baly A, Toledo Romaní ME.
    Rev Cubana Med Trop; 2005 Aug 05; 57(3):185-91. PubMed ID: 17969271
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Molecular size distribution assessment of Haemophilus influenzae vaccine containing lactose by HPAEC-PAD and colorimetric assays.
    Nadim AH, Hussein AR, Rezk MR, Fathalla FAA, El-Saharty YS.
    Anal Biochem; 2022 Sep 15; 653():114790. PubMed ID: 35724942
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. An NMR spectroscopic identity test for the control of the capsular polysaccharide from Haemophilus influenzae type b.
    Lemercinier X, Jones C.
    Biologicals; 2000 Sep 15; 28(3):175-83. PubMed ID: 10964444
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.